AEye, Inc. (AEye), a provider of high-performance, active lidar systems for vehicle autonomy, advanced driver-assistance systems, and robotic vision applications, has announced the filing of a prospectus supplement under Rule 424(b)(5) with the Securities and Exchange Commission (SEC). The filing pertains to an At Market Issuance Sales Agreement with A.G.P./Alliance Global Partners (A.G.P.) dated September 12, 2024, for the sale of up to $2,600,000 of AEye's common stock. The sales agreement allows AEye to offer and sell its common stock from time to time through A.G.P., acting as a sales agent. The common stock will be offered by any method permitted by law that is deemed an 'at the market offering' as defined...Show More

AEye, Inc. (AEye), a provider of high-performance, active lidar systems for vehicle autonomy, advanced driver-assistance systems, and robotic vision applications, has announced the filing of a prospectus supplement under Rule 424(b)(5) with the Securities and Exchange Commission (SEC). The filing pertains to an At Market Issuance Sales Agreement with A.G.P./Alliance Global Partners (A.G.P.) dated September 12, 2024, for the sale of up to $2,600,000 of AEye's common stock. The sales agreement allows AEye to offer and sell its common stock from time to time through A.G.P., acting as a sales agent. The common stock will be offered by any method permitted by law that is deemed an 'at the market offering' as defined in Rule 415 under the Securities Act of 1933. A.G.P. will receive a commission of up to 3.0% of the gross proceeds from any sales made under the agreement. The net proceeds from the sale will depend on the number of shares sold and the offering price of such shares. AEye's common stock is listed on The Nasdaq Capital Market under the symbol 'LIDR.' As of September 12, 2024, the last reported sale price of AEye's common stock was $1.06 per share. The company has highlighted the high degree of risk involved in investing in their common stock and has advised investors to read the 'Risk Factors' section of the prospectus supplement before investing.